Healthcare >> CEO Interviews >> April 28, 2003
JEFFREY D. TURNER is the Founder of Nexia Biotechnologies Inc.
and has served as President and Chief Executive Officer since its
inception. Prior to Nexia, Dr. Turner was an Associate Professor
(tenured) at McGill University, Montreal from 1987 to 1994, where
he maintained an active research program in dairy cattle
molecular genetics. Dr. Turner earned his PhD in Molecular
Biology from the University of Illinois (Urbana) in 1987. He
earned two MSc degrees: one from the University of Illinois
(Urbana, 1987) in Protein Chemistry and the other from McMaster
University (1982) in Animal Physiology. He has published over 50
peer-reviewed articlesand 100 abstracts at national and
international meetings. Dr. Turner serves on the Advisory Board
of T2C2/Bio 2000, a seed venture capital firm of Montreal; Board
of Directors -Textile Technology Center; NSERC Research
Partnership. Dr. Turner was the Chair, National Strategic
Biotechnology Program at NSERC (1997-1999) and is an ad hoc
reviewer for NSERC Cell Biology and USDA-Competitive Grants
Program. Dr. Turner was a Visiting Scientist with the U.S.
Antarctic Research Program (USARP), McMurdo Station, Antarctica
(1979 and 1983). Profile
Biotechnologies?
Dr. Turner: The business premise of Nexia Biotechnologies is the
cost-effective production of very complicated
